Stay updated on Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added a dedicated Locations section featuring Colorado as a study site and updated the page revision to v3.3.3; removed the Colorado Locations and HHS Vulnerability Disclosure items (and the older Revision: v3.3.2 reference).
    Difference
    0.2%
    Check dated 2025-12-24T15:27:52.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed in the page footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:53:54.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Removed the government funding lapse and operating status notice from the page. The study details, eligibility criteria, locations, and results plan remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T07:36:18.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The Study Details page content appears unchanged between the two screenshots.
    Difference
    0.4%
    Check dated 2025-10-27T21:08:31.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    2%
    Check dated 2025-10-06T08:58:13.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release.
    Difference
    0.1%
    Check dated 2025-09-29T07:30:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Binimetinib+Bevacizumab in Refractory CRC Clinical Trial page.